Bharat Bio consortium gets $19 m to develop ‘variant-proof’ vaccine
11
May
Bharat Bio consortium gets $19 m to develop ‘variant-proof’ vaccine Subject :Science and Technology Section: Biotech Context: An adjuvant subunit vaccine, designed to provide broad protection against all known SARS-CoV-2 variants Concept: The Coalition for Epidemic Preparedness Innovations (CEPI) was launched at Davos in 2017 as the result of a consensus that a […]